| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |